<- Go Home
Bellevue Life Sciences Acquisition Corp.
Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.
Market Cap
$45.4M
Volume
31.1K
Cash and Equivalents
$12.2K
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$13.40
52 Week Low
$10.45
Dividend
N/A
Price / Book Value
-7.88
Price / Earnings
-130.05
Price / Tangible Book Value
-7.88
Enterprise Value
$47.2M
Enterprise Value / EBITDA
N/A
Operating Income
-$2.2M
Return on Equity
11.57%
Return on Assets
-3.01
Cash and Short Term Investments
$12.2K
Debt
$1.9M
Equity
-$5.8M
Revenue
N/A
Unlevered FCF
-$216.4K
Sector
Capital Markets
Category
N/A